Our results are similar to those reported by Mydin et al. who were able to show that patients with a pre-SADT PSA ≤10 ng/mL in the absence of DM had improved overall survival post-definitive RT in a secondary analysis of Irish Clinical Oncology Research Group 97–01 [7]. Here, KLK3 is linked to diabetes mellitus.